Desktop Site
|
18 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
72,488.99
-454.69
-0.62 %
Corporate Announcement
Security Code
524804
Company
Aurobindo Pharma Ltd
Exchange Received Time
21/08/2017 08:46:43
Exchange Disseminated Time
21/08/2017 08:46:48
Time Taken
00:00:05
Press Release / Media Release |
8/21/2017 8:46:44 AM
Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate tablets
Attachment
<< Back
Recently Viewed